Filter By Unselect All
Sub Category Unselect
Country Unselect See All
Companies Unselect See All
Selected Filter(s): Reset All
- Category Reset
- Sub Category Reset
- Country Reset
Characterization studies for your product can be conducted prior to formulation. We specialize in the design and execution of pertinent pre-formulation activities required for successful pharmaceutical product development.
Comprehensive evaluation of drug candidates during pre-formulation is critical to the formulation development process. Specific challenges include low bioavailability, poor solubility and/or permeability, and poor physical stability.
Quotient Sciences has a proven track record of developing and manufacturing SDDs to overcome your poor drug solubility and delivery challenges. We tailor the development of your SDD toward the specific physical and biopharmaceutics properties of each molecule.
Globela Pharma Pvt Ltd has uplifted our existing R & D facility, and installed fully functioning in house R & D center- with state of the art infrastructure, and experienced, skilled manpower.
Glatt can optimize the active substance release and bioavailability by specific optimized formulation and process methods depending on the physico-chemical property of the active substance.
The Glatt MicroPX™ technology (micro pelletizing technology) is a continuous fluidized bed agglomeration procedure for the manufacture of pellets and micropellets with a very high active ingredient content.